Endocrinology

Busting brain myths: The evolving story of menopause hormone therapy and cognitive health
Today, experts agree that for many women who start MHT around menopause and don’t have medical reasons to avoid it, the benefits outweigh the risks, and MHT can be safely prescribed to manage menopause symptoms. Yet, several myths about MHT have persisted, including misperceptions about how it affects brain aging.
Wellness influencers constantly warn about high cortisol—what do your patients really need to know?
Many offer diet and exercise routines that they claim will help. But don't be so quick to label this hormone as a villain.

Refresher: What clinicians should know about lipedema

Often confused with obesity or lymphedema, lipedema is poorly understood in primary care. A Quebec update provides an overview of this chronic condition, its manifestations and management.
VTE risk with newer hormonal contraceptives

Venous thromboembolism is a recognized adverse event linked to hormonal contraceptives, with an increased risk related to higher estrogen dose and progestin type, in particular depot medroxyprogesterone acetate.
Health Canada approves first pill to treat postpartum depression

Zuranolone, sold under the brand name Zurzuvae, is a pill taken once a day for 14 days and can start relieving depressive symptoms in as few as three days.
Can’t take hormone therapy for menopause? What are other options?

Beyond lifestyle changes, some nonhormonal prescription medicines have been shown to ease menopausal symptoms.
Does breast cancer risk differ based on hormonal contraceptive ingredients?

Study estimates the difference in breast cancer risk associated with different hormonal contraceptive formulations in adolescents and premenopausal women.
Canadian menopausal hormone therapy dosage equivalency table now available

This new Canadian Menopause Society resource is designed to simplify menopausal hormone therapy and facilitate product comparisons.
Doctors want women to know the nuanced reality of hormone therapy for menopause

Doctors are divided over whether there should be changes in ‘black box’ health warnings on some hormone treatments.
Menopausal hormone therapy reduces fracture risk, even in the long term: study

Researchers analyzed the medical records of more than three million women aged 40 and over.

Busting brain myths: The evolving story of menopause hormone therapy and cognitive health

Wellness influencers constantly warn about high cortisol—what do your patients really need to know?

Refresher: What clinicians should know about lipedema

VTE risk with newer hormonal contraceptives

Health Canada approves first pill to treat postpartum depression

Can’t take hormone therapy for menopause? What are other options?

Does breast cancer risk differ based on hormonal contraceptive ingredients?

Canadian menopausal hormone therapy dosage equivalency table now available

Doctors want women to know the nuanced reality of hormone therapy for menopause

Menopausal hormone therapy reduces fracture risk, even in the long term: study